Trial Profile
A Randomized, Double-Blind, Parallel Group, Vehicle-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of Topical ATx201 OINTMENT in Adolescents and Adults with Mild to Moderate Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Jan 2023
Price :
$35
*
At a glance
- Drugs Niclosamide (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors UNION Therapeutics
- 09 Jan 2023 According to Union Therapeutics media release, the topline results are expected later in 2023.
- 28 Apr 2021 Status changed from recruiting to completed.
- 26 Nov 2020 This trial has been completed in Bulgaria according to European Clinical Trials Database record.